Frisina RD, Wheeler HE, Fossa SD, et al. Comprehensive audiometric analysis of hearing impairment and tinnitus after cisplatin-based chemotherapy in survivors of adult-onset cancer. J Clin Oncol. 2016;34(23):2712–20. https://doi.org/10.1200/JCO.2016.66.8822.
Article CAS PubMed PubMed Central Google Scholar
Schuette A, Lander DP, Kallogjeri D, et al. Predicting hearing loss after radiotherapy and cisplatin chemotherapy in patients with head and neck cancer. JAMA Otolaryngol Head Neck Surg. 2020;146(2):106–12. https://doi.org/10.1001/jamaoto.2019.3550.
Dillard LK, Lopez-Perez L, Martinez RX, Fullerton AM, Chadha S, McMahon CM. Global burden of ototoxic hearing loss associated with platinum-based cancer treatment: a systematic review and meta-analysis. Cancer Epidemiol. 2022;79:102203. https://doi.org/10.1016/j.canep.2022.102203.
Article PubMed PubMed Central Google Scholar
Cheung S, Henderson-Sabes J, Mastick J, et al. Cancer survivors and neurotoxic chemotherapy: hearing loss and tinnitus. BMJ Support Palliat Care. 2022. https://doi.org/10.1136/spcare-2022-003684
Breglio AM, Rusheen AE, Shide ED, et al. Cisplatin is retained in the cochlea indefinitely following chemotherapy. Nat Commun. 2017;8(1):1654. https://doi.org/10.1038/s41467-017-01837-1.
Article CAS PubMed PubMed Central Google Scholar
Ciorba A, Bianchini C, Pelucchi S, Pastore A. The impact of hearing loss on the quality of life of elderly adults. Clin Interv Aging. 2012;7:159–63. https://doi.org/10.2147/CIA.S26059.
Article PubMed PubMed Central Google Scholar
Buchmann L, Conlee J, Hunt J, Agarwal J, White S. Psychosocial distress is prevalent in head and neck cancer patients. Laryngoscope. 2013;123(6):1424–9. https://doi.org/10.1002/lary.23886.
Dixon PR, Feeny D, Tomlinson G, Cushing S, Chen JM, Krahn MD. Health-related quality of life changes associated with hearing loss. JAMA Otolaryngol Head Neck Surg. 2020;146(7):630–8. https://doi.org/10.1001/jamaoto.2020.0674.
Powell DS, Oh ES, Reed NS, Lin FR, Deal JA. Hearing loss and cognition: what we know and where we need to go. Front Aging Neurosci. 2021;13:769405. https://doi.org/10.3389/fnagi.2021.769405.
Tran Y, Tang D, Lo C, McMahon C, Mitchell P, Gopinath B. Co-occurring hearing loss and cognitive decline in older adults: a dual group-based trajectory modeling approach. Front Aging Neurosci. 2021;13:794787. https://doi.org/10.3389/fnagi.2021.794787.
Article PubMed PubMed Central Google Scholar
Miller KD, Nogueira L, Devasia T, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022;72(5):409–36. https://doi.org/10.3322/caac.21731.
Nader ME, Gidley PW. Challenges of hearing rehabilitation after radiation and chemotherapy. J Neurol Surg B Skull Base. 2019;80(2):214–24. https://doi.org/10.1055/s-0039-1677865.
Article PubMed PubMed Central Google Scholar
Strojan P, Hutcheson KA, Eisbruch A, et al. Treatment of late sequelae after radiotherapy for head and neck cancer. Cancer Treat Rev. 2017;59:79–92.
Article PubMed PubMed Central Google Scholar
(AAA) AAoA. Position statement and clinical practice guidelines: ototoxicity monitoring. 2009. www.audiology.org/practice-guideline/position-statement-and-practice-guidelines-on-ototoxicity-monitoring. Accessed 6 Mar 2023.
Association AS-L-H. Audiologic management of individuals receiving cochleotoxic drug therapy. 1994. https://doi.org/10.1044/policy.GL1994-00003
Konrad-Martin D, Poling GL, Garinis AC, et al. Applying US national guidelines for ototoxicity monitoring in adult patients perspectives on patient populations service gaps barriers and solutions. Int J Audiol. 2018;57(sup4):S3–18. https://doi.org/10.1080/14992027.2017.1398421.
Garinis AC, Cornell A, Allada G, Fennelly KP, Maggiore RJ, Konrad-Martin D. Ototoxicity monitoring through the eyes of the treating physician: perspectives from pulmonology and medical oncology. Int J Audiol. 2018;57(sup4):S19–24. https://doi.org/10.1080/14992027.2017.1381769.
Santucci NM, Garber B, Ivory R, Kuhn MA, Stephen M, Aizenberg D. Insight into the current practice of ototoxicity monitoring during cisplatin therapy. J Otolaryngol Head Neck Surg. 2021;50(1):19. https://doi.org/10.1186/s40463-021-00506-0.
Article CAS PubMed PubMed Central Google Scholar
Lee DS, Travis EY, Wong SK, et al. Audiologic follow-up in patients with head and neck cancer treated with cisplatin and radiation. Laryngoscope. 2023. https://doi.org/10.1002/lary.30682
Butler DC, Petterson S, Phillips RL, Bazemore AW. Measures of social deprivation that predict health care access and need within a rational area of primary care service delivery. Health Serv Res. 2013;48(2 Pt 1):539–59. https://doi.org/10.1111/j.1475-6773.2012.01449.x.
Hart LG, Larson EH, Lishner DM. Rural definitions for health policy and research. Am J Public Health. 2005;95(7):1149–55. https://doi.org/10.2105/AJPH.2004.042432.
Article PubMed PubMed Central Google Scholar
Rosenblatt RA, Andrilla CH, Curtin T, Hart LG. Shortages of medical personnel at community health centers: implications for planned expansion. JAMA. 2006;295(9):1042–9. https://doi.org/10.1001/jama.295.9.1042.
Article CAS PubMed Google Scholar
Massa ST, Mazul AL, Puram SV, Pipkorn P, Zevallos JP, Piccirillo JF. Association of demographic and geospatial factors with treatment selection for laryngeal cancer. JAMA Otolaryngol Head Neck Surg. 2021;147(7):590–8. https://doi.org/10.1001/jamaoto.2021.0453.
Kind AJH, Buckingham WR. Making neighborhood-disadvantage metrics accessible - the Neighborhood Atlas. N Engl J Med. 2018;378(26):2456–8. https://doi.org/10.1056/NEJMp1802313.
Article PubMed PubMed Central Google Scholar
Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL Jr. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA. 2004;291(20):2441–7. https://doi.org/10.1001/jama.291.20.2441.
Article CAS PubMed Google Scholar
Amin MB, Greene FL, Edge SB, et al. The eighth edition AJCC cancer staging manual continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. Mar 2017;67(2):93–99. https://doi.org/10.3322/caac.21388
Chiou SH, Xu G, Yan J, Huang C-Y. Regression modeling for recurrent events possibly with an informative terminal event using R package reReg. J Stat Soft. 2023;105(1):134. https://doi.org/10.18637/jss.v105.i05
Therneau TM, Grambsch PM. Modeling survival data: extending the Cox model. 1st ed. Statistics for biology and health. Springer New York: Imprint: 2000.
Bhandare N, Antonelli PJ, Morris CG, Malayapa RS, Mendenhall WM. Ototoxicity after radiotherapy for head and neck tumors. Int J Radiat Oncol Biol Phys. 2007;67(2):469–79. https://doi.org/10.1016/j.ijrobp.2006.09.017.
Schmitt NC, Page BR. Chemoradiation-induced hearing loss remains a major concern for head and neck cancer patients. Int J Audiol. 2018;57(sup4):S49–54. https://doi.org/10.1080/14992027.2017.1353710.
Konrad-Martin D, Polaski R, DeBacker JR, et al. Audiologists’ perceived value of ototoxicity management and barriers to implementation for at-risk cancer patients in VA: the OtoMIC survey. J Cancer Surviv. 2023;17(1):69–81. https://doi.org/10.1007/s11764-022-01316-7.
Article PubMed PubMed Central Google Scholar
Pearson SE, Caimino C, Shabbir M, Baguley DM. The impact of chemotherapy-induced inner ear damage on quality of life in cancer survivors: a qualitative study. J Cancer Surviv. 2021. https://doi.org/10.1007/s11764-021-01089-5
Pearson SE, Taylor J, Patel P, Baguley DM. Cancer survivors treated with platinum-based chemotherapy affected by ototoxicity and the impact on quality of life: a narrative synthesis systematic review. Int J Audiol. 2019;58(11):685–95. https://doi.org/10.1080/14992027.2019.1660918.
Ehlert K, Heinze B, Swanepoel W. Ototoxicity monitoring in South African cancer facilities: a national survey. S Afr J Commun Disord. 2022;69(1):e1–10. https://doi.org/10.4102/sajcd.v69i1.846.
Paken J, Govender CD, Pillay M, Sewram V. Perspectives and practices of ototoxicity monitoring. S Afr J Commun Disord. 2020;67(1):e1–10. https://doi.org/10.4102/sajcd.v67i1.685.
Maru D, Malky GA. Current practice of ototoxicity management across the United Kingdom (UK). Int J Audiol. 2018;57(sup4):S76–88. https://doi.org/10.1080/14992027.2018.1460495.
National Academies of Sciences E, Medicine. Hearing health care for adults: priorities for improving access and affordability. National Academies Press. 2016.
Durrant JD, Palmer CV, Lunner T. Analysis of counted behaviors in a single-subject design: modeling of hearing-aid intervention in hearing-impaired patients with Alzheimer’s disease. Int J Audiol. 2005;44(1):31–8. https://doi.org/10.1080/14992020400022637.
Ardeshirrouhanifard S, Fossa SD, Huddart R, et al. Ototoxicity after cisplatin-based chemotherapy: factors associated with discrepancies between patient-reported outcomes and audiometric assessments. Ear Hear May/Jun. 2022;43(3):794–807. https://doi.org/10.1097/AUD.0000000000001172.
Boelhouwer IG, Vermeer W, van Vuuren T. Late effects of cancer treatment, job resources, and burnout complaints among employees with a breast cancer diagnosis 2–10 years ago: a longitudinal study. Front Psychol. 2021;12:793138. https://doi.org/10.3389/fpsyg.2021.793138.
Dewyer NA, Jiradejvong P, Lee DS, Kemmer JD, Henderson Sabes J, Limb CJ. Automated smartphone audiometry: a preliminary validation of a bone-conduction threshold test app. Ann Otol Rhinol Laryngol. 2019;128(6):508–15. https://doi.org/10.1177/0003489419828770.
留言 (0)